Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Arcus Biosciences Inc (NYSE: RCUS) closed at $11.07 in the last session, up 3.07% from day before closing price of $10.74. In other words, the price has increased by $3.07 from its previous closing price. On the day, 1.24 million shares were traded.
Ratios:
We take a closer look at RCUS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.23 and its Current Ratio is at 5.23. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on October 21, 2024, initiated with a Neutral rating and assigned the stock a target price of $20.
On October 08, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $29.
On November 18, 2022, BofA Securities started tracking the stock assigning a Neutral rating and target price of $33.BofA Securities initiated its Neutral rating on November 18, 2022, with a $33 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when GILEAD SCIENCES, INC. bought 1,363,636 shares for $11.00 per share. The transaction valued at 14,999,996 led to the insider holds 31,424,760 shares of the business.
Goeltz II Robert C. sold 3,594 shares of RCUS for $53,910 on Dec 31 ’24. The Chief Financial Officer now owns 60,138 shares after completing the transaction at $15.00 per share. On Dec 31 ’24, another insider, Goeltz II Robert C., who serves as the Officer of the company, bought 3,594 shares for $15.00 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.43 while its Price-to-Book (P/B) ratio in mrq is 1.79.
Stock Price History:
Over the past 52 weeks, RCUS has reached a high of $20.31, while it has fallen to a 52-week low of $10.63. The 50-Day Moving Average of the stock is -21.92%, while the 200-Day Moving Average is calculated to be -29.02%.
Shares Statistics:
A total of 91.50M shares are outstanding, with a floating share count of 59.66M. Insiders hold about 43.28% of the company’s shares, while institutions hold 49.57% stake in the company.
